Related Experiment Video
Updated: Jun 22, 2026
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
[Anti-HER2 vaccines: The HER2 immunotargeting future?]
M Z Ladjemi1, W Jacot, A Pèlegrin
1Inserm U896, CRLC Val-d'Aurelle Paul-Lamarque, institut de recherche en cancérologie de Montpellier (IRCM), université Montpellier-1, 34298 Montpellier cedex 5, France. maha-zohra.ladjemi@valdorel.fnclcc.fr
Pathologie-Biologie
|June 2, 2009
Summary
Developing HER2 cancer vaccines aims to prevent breast cancer recurrence. Overcoming immune tolerance to HER2 is key for effective anti-cancer immunity and long-term protection against metastatic disease.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Context:
- Breast cancer metastasis remains a significant challenge, particularly in HER2-overexpressing cases.
- Existing HER2 immunotherapies show promise, highlighting the potential of immune responses against HER2.
- Tumor-specific immune responses are linked to reduced tumor development in early disease stages.
Purpose:
- To review current and preclinical anti-HER2 vaccine strategies for breast cancer.
- To explore methods for breaking immunological tolerance to HER2.
- To discuss diverse antigen delivery systems and approaches for cancer vaccines.
Summary:
- HER2-overexpressing breast cancers are prone to relapse, despite advances in treatment.
- Anti-HER2 immune responses correlate with better outcomes, suggesting vaccine potential.
- Strategies involve various HER2-specific antigens (cells, DNA, peptides, proteins) and delivery methods (dendritic cells, anti-idiotypic antibodies).
Impact:
- Successful HER2 vaccines could induce lasting immune memory, preventing tumor recurrence.
- Overcoming HER2 tolerance is crucial for developing effective preventative and therapeutic cancer vaccines.
- This research informs the development of novel immunotherapies for HER2+ breast cancer.
More Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...